u/ImBadAtIt · 100d agono track record yet
“taking the gamble”
OTLK - ONS-5010/LYTENAVA
OTLK resubmitted its BLA to the FDA with a decision expected by end of July. Approval of ONS-5010/LYTENAVA could capture a meaningful market share, offering significant upside despite the early-stage risk profile.
At post $1.70Now $0.65-61.6% since postedas of Sep 18, 4:30 PM ET
1d-1.2%
3d+0.6%
1w-6.5%
1m-22.4%
3m—
6m—
1y—